| Financial Year |
March 31 2023 |
| Monetary Funds |
502,910,026.84 |
| Held-for-trading Financial Assets |
1,803,829,166.74 |
| Notes Receivable |
-- |
| Accounts Receivable |
147,791,757.28 |
| Advances to Suppliers |
37,697,730.44 |
| Other Receivables |
9,941,162.78 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
53,908,934.18 |
| Total Current Assets |
2,556,078,778.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
75,857,152.80 |
| Investment Properties |
-- |
| Fixed Assetes |
19,092,251.02 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
943,038.67 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,545,364.35 |
| Deferred Income Tax Assets |
30,829,461.88 |
| Other Non-Current Assets |
10,652,539.30 |
| Sub-Total of Non-Current Assets |
245,577,671.75 |
| Total Assets |
2,801,656,450.01 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
6,201,840.54 |
| Accounts Received In Advance |
1,748,492.53 |
| Employee Compensation Payable |
94,081,156.31 |
| Taxes Payable |
58,991,144.57 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
173,043,539.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
20,240,383.27 |
| Other Current Liabilities |
330,769,910.73 |
| Sub-Total of Current Liabilities |
793,504,905.79 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
574,375.01 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
36,086,286.21 |
| Total Liabilities |
829,591,192.00 |
| Paid-In Capital(Or Share Stock) |
152,537,820.00 |
| Capital Surplus |
913,159,293.88 |
| Surplus Reserve |
76,194,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
870,298,966.26 |
| Minority Stockholder's Interest |
-28,432,477.67 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,000,497,735.68 |
| Owner's Equity（Stockholder's Equity） |
1,972,065,258.01 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,801,656,450.01 |
